New Insights Into Hepatic Impairment (HI) Trials

New Insights Into Hepatic Impairment (HI) Trials

ABSTRACT Hepatic impairment (HI) trials are traditionally part of the clinical pharmacology development to assess the need for dose adaptation in people with impaired metabolic capacity due to their diseased liver. This review aimed at looking into the data from dedicated HI studies, cluster these d...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastian Haertter, Maximilian Lobmeyer, Brian C. Ferslew, Pallabi Mitra, Thomas Arnhold
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Clinical and Translational Science
Subjects:
ADME
hepatic impairment
IQ working group
literature search
pharmacokinetics (PK)
Online Access:https://doi.org/10.1111/cts.70130
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items